The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation

Irene Marchesi, Francesco Paolo Fiorentino, Flavio Rizzolio, Antonio Giordano, Luigi Bagella

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Rhabdomyosarcoma (RMS) is a pediatric tumor that arises from muscle precursor cells. RMS cells express several markers of early myogenic diferentiation, but they fail to complete both diferentiation program and cell cycle arrest, resulting in uncontrolled proliferation and incomplete myogenesis. previous studies showed that eZH2, which is involved in both diferentiation and cancer progression, is overexpressed in RMS, but a functional binding between its expression and its functional role in tumor formation or progression has not yet been demonstrated. We hypothesized that eZH2 is a key regulator of muscular diferentiation program in RMS cells. In this study, we demonstrated that eZH2 directly binds muscle specifc genes in RD cells. Silencing of eZH2 promotes the recruitment of a multiprotein complex at muscle-specifc promoters, their transcriptional activation and protein expression. Moreover, we demonstrated that eZH2 is directly involved in transcriptional repression of MyoD, the main factor promoting myogenesis. eZH2 ablation induces MyoD activation the recovery of its binding on muscle-specifc genes.

Original languageEnglish
Pages (from-to)3828-3836
Number of pages9
JournalCell Cycle
Volume11
Issue number20
DOIs
Publication statusPublished - Oct 15 2012

Fingerprint

Rhabdomyosarcoma
Muscle Development
Muscles
MyoD Protein
Multiprotein Complexes
Neoplasms
Myoblasts
Cell Cycle Checkpoints
Transcriptional Activation
Genes
Pediatrics
Proteins

Keywords

  • EZH2
  • MyoD
  • Myogenesis
  • PRC complex
  • Rhabdomyosarcoma

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Developmental Biology

Cite this

Marchesi, I., Fiorentino, F. P., Rizzolio, F., Giordano, A., & Bagella, L. (2012). The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation. Cell Cycle, 11(20), 3828-3836. https://doi.org/10.4161/cc.22025

The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation. / Marchesi, Irene; Fiorentino, Francesco Paolo; Rizzolio, Flavio; Giordano, Antonio; Bagella, Luigi.

In: Cell Cycle, Vol. 11, No. 20, 15.10.2012, p. 3828-3836.

Research output: Contribution to journalArticle

Marchesi, I, Fiorentino, FP, Rizzolio, F, Giordano, A & Bagella, L 2012, 'The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation', Cell Cycle, vol. 11, no. 20, pp. 3828-3836. https://doi.org/10.4161/cc.22025
Marchesi I, Fiorentino FP, Rizzolio F, Giordano A, Bagella L. The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation. Cell Cycle. 2012 Oct 15;11(20):3828-3836. https://doi.org/10.4161/cc.22025
Marchesi, Irene ; Fiorentino, Francesco Paolo ; Rizzolio, Flavio ; Giordano, Antonio ; Bagella, Luigi. / The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation. In: Cell Cycle. 2012 ; Vol. 11, No. 20. pp. 3828-3836.
@article{fae1ebebe6fc4d1dbdd22b1b5dba69a5,
title = "The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation",
abstract = "Rhabdomyosarcoma (RMS) is a pediatric tumor that arises from muscle precursor cells. RMS cells express several markers of early myogenic diferentiation, but they fail to complete both diferentiation program and cell cycle arrest, resulting in uncontrolled proliferation and incomplete myogenesis. previous studies showed that eZH2, which is involved in both diferentiation and cancer progression, is overexpressed in RMS, but a functional binding between its expression and its functional role in tumor formation or progression has not yet been demonstrated. We hypothesized that eZH2 is a key regulator of muscular diferentiation program in RMS cells. In this study, we demonstrated that eZH2 directly binds muscle specifc genes in RD cells. Silencing of eZH2 promotes the recruitment of a multiprotein complex at muscle-specifc promoters, their transcriptional activation and protein expression. Moreover, we demonstrated that eZH2 is directly involved in transcriptional repression of MyoD, the main factor promoting myogenesis. eZH2 ablation induces MyoD activation the recovery of its binding on muscle-specifc genes.",
keywords = "EZH2, MyoD, Myogenesis, PRC complex, Rhabdomyosarcoma",
author = "Irene Marchesi and Fiorentino, {Francesco Paolo} and Flavio Rizzolio and Antonio Giordano and Luigi Bagella",
year = "2012",
month = "10",
day = "15",
doi = "10.4161/cc.22025",
language = "English",
volume = "11",
pages = "3828--3836",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "20",

}

TY - JOUR

T1 - The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation

AU - Marchesi, Irene

AU - Fiorentino, Francesco Paolo

AU - Rizzolio, Flavio

AU - Giordano, Antonio

AU - Bagella, Luigi

PY - 2012/10/15

Y1 - 2012/10/15

N2 - Rhabdomyosarcoma (RMS) is a pediatric tumor that arises from muscle precursor cells. RMS cells express several markers of early myogenic diferentiation, but they fail to complete both diferentiation program and cell cycle arrest, resulting in uncontrolled proliferation and incomplete myogenesis. previous studies showed that eZH2, which is involved in both diferentiation and cancer progression, is overexpressed in RMS, but a functional binding between its expression and its functional role in tumor formation or progression has not yet been demonstrated. We hypothesized that eZH2 is a key regulator of muscular diferentiation program in RMS cells. In this study, we demonstrated that eZH2 directly binds muscle specifc genes in RD cells. Silencing of eZH2 promotes the recruitment of a multiprotein complex at muscle-specifc promoters, their transcriptional activation and protein expression. Moreover, we demonstrated that eZH2 is directly involved in transcriptional repression of MyoD, the main factor promoting myogenesis. eZH2 ablation induces MyoD activation the recovery of its binding on muscle-specifc genes.

AB - Rhabdomyosarcoma (RMS) is a pediatric tumor that arises from muscle precursor cells. RMS cells express several markers of early myogenic diferentiation, but they fail to complete both diferentiation program and cell cycle arrest, resulting in uncontrolled proliferation and incomplete myogenesis. previous studies showed that eZH2, which is involved in both diferentiation and cancer progression, is overexpressed in RMS, but a functional binding between its expression and its functional role in tumor formation or progression has not yet been demonstrated. We hypothesized that eZH2 is a key regulator of muscular diferentiation program in RMS cells. In this study, we demonstrated that eZH2 directly binds muscle specifc genes in RD cells. Silencing of eZH2 promotes the recruitment of a multiprotein complex at muscle-specifc promoters, their transcriptional activation and protein expression. Moreover, we demonstrated that eZH2 is directly involved in transcriptional repression of MyoD, the main factor promoting myogenesis. eZH2 ablation induces MyoD activation the recovery of its binding on muscle-specifc genes.

KW - EZH2

KW - MyoD

KW - Myogenesis

KW - PRC complex

KW - Rhabdomyosarcoma

UR - http://www.scopus.com/inward/record.url?scp=84868014011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868014011&partnerID=8YFLogxK

U2 - 10.4161/cc.22025

DO - 10.4161/cc.22025

M3 - Article

C2 - 22983009

AN - SCOPUS:84868014011

VL - 11

SP - 3828

EP - 3836

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 20

ER -